Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2019-01-22 Interim / Quarterly Rep…
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Appendix 4C and Notes to Appendix 4C 9 pages 563.4KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement titled 'CELLMID LIMITED NOTES TO THE APPENDIX 4C' and includes detailed financial data for the quarter ending 31 December 2018. It contains a consolidated statement of cash flows, cash balances, receipts, payments, and other financial activities for the quarter and year to date. The document references the Appendix 4C Quarterly Cash Flow report, which is a regulatory filing required by the ASX for quarterly reporting of cash flows and financial activities. The content is comprehensive and includes actual financial data and analysis for the quarter, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), as it provides a comprehensive financial report for a period shorter than a full fiscal year with substantive financial data and analysis. Q2 2019
2019-01-22 English
Cellmid Expects Record Sales in Q2 FY2019 2 pages 222.5KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement from Cellmid Limited dated December 12, 2018, discussing expected record sales in Q2 FY2019. It provides sales figures, margin improvements, and business updates related to sales channels and product distribution. The content focuses on sales performance and operational updates rather than detailed financial statements or comprehensive financial analysis. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing or certification. The document is a company announcement updating the market on sales and business progress, which fits best under Capital/Financing Update (CAP) as it relates to sales and revenue updates impacting the company's financial position and capital outlook.
2018-12-11 English
Cellmid Appoints Exclusive New Zealand Distributor 2 pages 223.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Cellmid Limited about appointing an exclusive distributor in New Zealand for its anti-aging consumer products. It discusses the distribution agreement, marketing plans, and company background. There is no financial data, no mention of a report or filing, no regulatory certification, no voting results, no management changes, no earnings or capital updates, and no legal or merger information. The document is a corporate announcement about a commercial partnership and distribution arrangement. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-11-18 English
Change of Director's Interest Notice - Eck 2 pages 346.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in shareholding, including the number of shares held before and after the change, the nature of the transaction, and dates. This matches the description of a Director's Dealing report, which involves personal share transactions by company directors and executives. The document length is 3402 characters, which is consistent with a detailed notice of director's interest change rather than a full financial report or announcement. There is no indication of financial results, management discussion, or other report types. Therefore, the correct classification is Director's Dealing (DIRS).
2018-11-12 English
Change of Director's Interest Notice - Halasz 3 pages 352.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the interest, and dates of changes. This is a report of personal share transactions by a company director. The document length is 4099 characters, which is consistent with a detailed director's dealing notice. There is no indication of financial results, management discussion, or other report types. Therefore, this document fits the definition of Director's Dealing (DIRS).
2018-11-12 English
Appendix 3B and Cleansing Notice 14 pages 922.9KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new fully paid ordinary shares, including the number of securities issued, terms, issue price, purpose, and approvals related to the issuance. It references ASX rules and compliance, and includes a calculation of placement capacity under ASX rules 7.1 and 7.1A. The content is consistent with a formal announcement of new share issuance and application for quotation of additional securities on the ASX. There is no indication that this is a full financial report, audit report, or earnings release. It is not a proxy statement, AGM material, or management discussion. The document is a regulatory announcement specifically about capital raising and share issuance. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length and detail support a high confidence in this classification.
2018-11-11 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.